Greenberg PE - Search Results

1

Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs.

Wu EQ, Greenberg PE, Yang E, Yu AP, Ben-Hamadi R, Erder MH. Wu EQ, et al. Among authors: greenberg pe. J Med Econ. 2009 Jun;12(2):124-35. doi: 10.3111/13696990903093537. J Med Econ. 2009. PMID: 19566483 Free article.

2

Economic burden of pneumonia in an employed population.

Birnbaum HG, Morley M, Greenberg PE, Cifaldi M, Colice GL. Birnbaum HG, et al. Among authors: greenberg pe. Arch Intern Med. 2001 Dec 10-24;161(22):2725-31. doi: 10.1001/archinte.161.22.2725. Arch Intern Med. 2001. PMID: 11732939

3

The economics of women and depression: an employer's perspective.

Birnbaum HG, Leong SA, Greenberg PE. Birnbaum HG, et al. Among authors: greenberg pe. J Affect Disord. 2003 Mar;74(1):15-22. doi: 10.1016/s0165-0327(02)00427-5. J Affect Disord. 2003. PMID: 12646295

4

Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.

Birnbaum HG, Shi L, Dial E, Oster EF, Greenberg PE, Mallett DA. Birnbaum HG, et al. Among authors: greenberg pe. J Clin Psychiatry. 2003 Oct;64(10):1201-9. doi: 10.4088/jcp.v64n1010. J Clin Psychiatry. 2003. PMID: 14658969

5

Economic implications of treatment-resistant depression among employees.

Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A. Greenberg P, et al. Pharmacoeconomics. 2004;22(6):363-73. doi: 10.2165/00019053-200422060-00003. Pharmacoeconomics. 2004. PMID: 15099122

6

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR. Birnbaum HG, et al. Among authors: greenberg pe. Curr Med Res Opin. 2005 Feb;21(2):195-206. doi: 10.1185/030079904X20303. Curr Med Res Opin. 2005. PMID: 15801990

7

Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients.

Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Swensen A, et al. J Adolesc Health. 2004 Oct;35(4):346.e1-9. J Adolesc Health. 2004. PMID: 15830457

8

Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.

Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP. Birnbaum HG, et al. Among authors: greenberg pe. Clin J Pain. 2006 Oct;22(8):667-76. doi: 10.1097/01.ajp.0000210915.80417.cf. Clin J Pain. 2006. PMID: 16988561

9

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

Wu E, Greenberg PE, Yang E, Yu A, Erder MH. Wu E, et al. Among authors: greenberg pe. Curr Med Res Opin. 2008 Sep;24(9):2587-95. doi: 10.1185/03007990802303525. Epub 2008 Jul 31. Curr Med Res Opin. 2008. PMID: 18674407

10

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.

Wu E, Greenberg P, Yang E, Yu A, Ben-Hamadi R, Erder MH. Wu E, et al. Curr Med Res Opin. 2008 Oct;24(10):2805-13. doi: 10.1185/03007990802336780. Epub 2008 Aug 27. Curr Med Res Opin. 2008. PMID: 18755054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters